Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2022.552 | Phase 3 Multicenter, Randomized, Double-Blind, Study to Assess the Efficacy and Safety of Treatment with Bepirovirsen in Nucleos(t)ide Analogue-treated Participants with Chronic Hepatitis B Virus (B-Well 1) |
Prof. WONG Grace Lai Hung 黃麗虹 |
| 2013.551 | A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg-Positive, Chronic Hepatitis B | Prof. WONG Grace Lai Hung |
| 2013.105 | A randomized controlled trial on the efficacy of tenofovir disoproxil fumarate (TDF)-switch therapy in chronic hepatitis B patients with incomplete response to entecavir | Dr. WONG Grace Lai Hung |
| 2012.357 | An open-label trial of 48-week peginterferon alfa-2a (PEGASYS) to assess the sustained response of chronic hepatitis B patients with HBeAg seroconversion on nucleot(s)ide analogue therapy | Prof. WONG Grace Lai Hung |
| 2009.381 | Prevention of recurrent idiopathic gastroduoden ulcer bleeding: a double-blind randomized trial | Dr. WONG Grace Lai Hung |
| 2013.316 | A randomized controlled trial of a new screening strategy for varices based on liver and spleen stiffness measurement (LSSM) in cirrhotic patients | Dr. WONG Grace Lai Hung |
| 2017.419 | Prevention of recurrent ulcer bleeding in patients with idiopathic gastroduodenal ulcer: a double-blind randomised trial on misoprostol combined with lansoprazole versus lansoprazole alone (NRT_MISO Study) |
Dr. WONG Grace Lai Hung 黃麗虹 |
| 2014.690 | Secular trend of etiologies of hepatocellular carcinoma (HCC) - a retrospective observational cohort study | Dr. WONG Grace Lai Hung |
| 2016.140 | Dynamic change of liver and spleen stiffness measurement (LSSM) to predict incident varices in cirrhotic patients |
Dr. WONG Grace Lai Hung 黃麗虹 |
| 2014.537 | Residual intrahepatic viral replication and the development of hepatocellular carcinoma in patients with chronic hepatitis B on oral nucleos(t)ide analogues: A longitudinal study with serial serum hepatitis B virus RNA measurement | Dr. WONG Grace Lai Hung |
| 2015.089 | Dynamic change of LSM-HCC score and enhanced liver fibrosis (ELF) score to predict hepatocellular carcinoma (HCC) in chronic hepatitis B patients receiving antiviral treatment |
Prof. WONG Grace Lai Hung 黃麗虹 |
| 2017.421 | Secular trend of deaths - a retrospective observational cohort study |
Dr. WONG Grace Lai Hung 黃麗虹 |
| 2016.595 | Secular trend of viral hepatitis - a retrospective observational cohort study |
Dr. WONG Grace Lai Hung 黃麗虹 |
| 2016.005 | REAL-C: Real-World Evidence from the Asia Liver Consortium for HCV |
Dr. WONG Grace Lai Hung 黃麗虹 |
| 2016.224 | Impact of long-term tenofovir disoproxil fumarate (TDF) treatment on the risk of HCC in patients with chronic hepatitis B related cirrhosis |
Dr. WONG Grace Lai Hung 黃麗虹 |
| 2017.214 | Risk of hepatocellular carcinoma in patients with chronic hepatitis B achieved complete viral suppression – role of on-treatment hepatitis B surface/core-related antigen (HBsAg/HBcrAg) levels |
Dr. WONG Grace Lai Hung 黃麗虹 |
| 2015.121 | Secular trend of etiologies of hepatic events - a retrospective observational cohort study |
Dr. WONG Grace Lai Hung 黃麗虹 |
| 2013.118 | Evaluation of clinical outcomes in patients with viral hepatitis B or C - a retrospective observational cohort study | Dr. WONG Grace Lai Hung |
| 2009.169 | Prevalence of Advanced Fibrosis among Chronic Hepatitis C Patients in Hong Kong | Prof. WONG Grace Lai Hung |
| 2020.310 | A Phase 2a, Multicenter, Single-Blind, Placebo-Controlled Study Evaluating Treatment Intensification with ABI-H0731 in Subjects with Chronic Hepatitis B Infection on Nucleos(t)ide Reverse Transcriptase Inhibitors | Prof. WONG Grace Lai Hung |
| 2020.090 | Serum fibrosis scores based on common laboratory parameters to guide screening strategies for early identification of hepatocellular carcinoma in patients with chronic hepatitis B |
Dr. WONG Grace Lai Hung 黃麗虹 |
| 2019.348 | Tenofovir alafenamide (TAF) treatment uptake and impact on ALT normalization in patients with chronic hepatitis B in Hong Kong – real-world cohort study (TAF-RW-HK study) | Dr. WONG Grace Lai Hung |
| 2020.074 | Secular trend of coronavirus infections - a retrospective observational cohort study |
Dr. WONG Grace Lai Hung 黃麗虹 |
| 2018.177 | Secular trend of hepatic events in patients with diabetes mellitus - a retrospective observational cohort study |
Dr. WONG Grace Lai Hung 黃麗虹 |
| 2020.459 | Elimination of chronic hepatitis B in Hong Kong – to meet the WHO goals |
Prof. WONG Grace Lai Hung 黃麗虹 |
| 2018.297 | A Phase 2, Randomized, Open-Label, Active-Controlled Study to Evaluate the Safety and Antiviral Activity of GS-9992 Plus Tenofovir Alafenamide (TAF) for 12 Weeks in Chronic Hepatitis B (CHB) Subjects |
Prof. WONG Grace Lai Hung 陳力元教授 |
| 2019.260 | AN OBSERVER BLIND, RANDOMIZED STUDY WITH AN OPEN LABEL PART TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF SUBCUTANEOUS ADMINISTRATION OF RO7191863 WITH MULTIPLE DOSES AND DIFFERENT REGIMENS IN VIROLOGICALLY SUPPRESSED PATIENTS WITH CHRONIC HEPATITIS B INFECTION |
Prof. WONG Grace Lai Hung 陳力元 |
| 2020.544 | Deep learning of combined clinical data and CT images in patients with chronic viral hepatitis – risk prediction and complication reduction to facilitate eliminating viral hepatitis by year 2030 |
Prof. WONG Grace Lai Hung 黃麗虹 |
| 2020.615 | Evaluation of AFP, AFP-L3, PIVKA-II and GALAD Score (Gender, Age, AFP-L3, AFP, DCP/PIVKA-II) for risk assessment of Hepatocellular Carcinoma (HCC) | Prof. WONG Grace Lai Hung |
| 2019.690 | Response after End of Treatment with Antivirals in Chronic Hepatitis B | Prof. WONG Grace Lai Hung |
| 2018.647 | Gastrointestinal and hepatic adverse events of immune checkpoint inhibitors (ICI) - a territory-wide observational cohort study | Dr. WONG Grace Lai Hung |
| 2020.509 | A Phase 2a, Multicenter, Single-Blind, Placebo-Controlled, Multiple Cohort Study Evaluating ABI-H2158-Containing Regimens in Chronic Hepatitis B Infection |
Prof Wong Grace Lai Hung 黃麗虹 |
| 2018.188 | Machine Learning Model to Predict Clinical Events in Patients with History of Peptic Ulcer Bleeding | Dr. WONG Grace Lai Hung |
| 2018.646 | Disease burden of chronic viral hepatitis in Hong Kong – towards eliminating viral hepatitis by year 2030 according to World Health Organization (WHO) targets | Dr. WONG Grace Lai Hung |
| 2019.399 | Role of cryoglobulin in patients with chronic kidney disease | Dr. WONG Grace Lai Hung |
| 2018.178 | A novel NAFLD-LE model based on liver stiffness measurement and enhanced liver fibrosis (ELF) to predict clinical events in patients with non-alcoholic fatty liver disease |
Dr. WONG Grace Lai Hung 黃麗虹 |
| 2018.554 | A Phase 1b Open-Label, Proof of Concept Study to Evaluate the Safety and Efficacy of Novel Hepatitis B Virus (HBV) Combination Therapies in Chronic Hepatitis B (CHB) Subjects | Prof. WONG Grace Lai Hung |
| 2013.550 | A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg-Negative, Chronic Hepatitis B | Prof. WONG Grace Lai Hung |
| 2021.239 | Retrospective cohort study for early detection of new-onset chronic diseases in recovered COVID-19 patients using population-based datasets | Prof. WONG Grace Lai Hung |
| 2022.656 | A Phase 2a, Randomized, Blinded, Multicenter Study Investigating a Combination of AB-729 and VTP-300 in Virologically-Suppressed Chronic Hepatitis B Participants | Prof. WONG Grace Lai Hung |
| 2021.443 | Portable liver scans for suspected and confirmed liver diseases |
Prof. WONG Grace Lai Hung 黃麗虹 |
| 2021.091 | Comparative Risk of HCC in CHB Patients Receiving ETV or TDF-based Treatment: IPD Meta-Analysis Protocol |
Dr WONG Grace Lai-Hung 黃麗虹 |
| 2019.070 | Deep learning in clinical parameters to predict hepatic events |
Prof. WONG Grace Lai-Hung 黃麗虹 |
| 2021.156 | Development of a novel nanoparticle-based indicator for rapid point-of-care detection of COVID-19 |
Dr. WONG Hei 黃曦 |
| 2014.022 | A Prospective Study to Characterize the Management and Outcome of Clostridium Difficile Infection in Asian Pacific Countries | Dr. Wong Hei Sunny |
| 2018.300 | Retrospectice review on gastric perforation in neonates in the Chinese population |
Dr. WONG Hei Yi 黃希夷 |
| 2015.226 | Prospective study on the prevalence of patent processus vaginalis in asymptomatic paediatric patient who receives laparoscopic surgery | Dr. WONG Hei Yi |
| 2016.073 | Effect of Wellness Recovery Action Plan on mental wellbeing among college students who are at risk for depression or anxiety: A randomized controlled trial |
Mr. WONG Henry Cheuk Yin 王卓然 |
| 2014.484 | A social-ecological approach to investigating childhood obesity risk during transition period from primary to secondary schools | Prof Wong Heung Sang Stephen |
| 2012.140 | Effect of an innovative herbal supplementation on oxidative stress and muscle micro-damage after exercise in healthy males: a double-blinded corssover-designed experimental study | Prof. Wong Heung-Sang Stephen |
Page 228 of 262.